102 Alternatively, various groups are advocating for the incorporation of novel markers, for instance a sophisticated karyotype55 or epigenetic subsets, 27,28 into scientific follow. All these novel prognostic and/or predictive products will must be validated in cohorts of sufferers treated with spe